Profil
Alan C.
Herman was the founder of Coherus Oncology, Inc., founded in 2010, where the title held was Chief Scientific Officer.
Dr. Herman was the founder of Windrose Analytica, Inc., founded in 2005, where the title held was Chief Executive Officer from 2005 to 2009.
Dr. Herman is also the founder of Windrose Medical Properties Trust.
Former jobs include Senior Director-Quality Control at Tercica, Inc., Principal at Merck & Co., Inc., and Chief Scientific Officer & VP-Product Development at Ajinomoto Althea, Inc. from 2009 to 2011.
Education includes a doctorate from Duke University and undergraduate and graduate degrees from Indiana University of Pennsylvania.
Anciens postes connus de Alan Herman
| Sociétés | Poste | Fin |
|---|---|---|
Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Provides products and services to support pharmaceutical companies | Directeur Technique/Scientifique/R&D | 01/04/2011 |
Windrose Analytica, Inc. | Directeur Général | 01/01/2009 |
| COHERUS ONCOLOGY, INC. | Fondateur | - |
Windrose Medical Properties Trust
Windrose Medical Properties Trust Real Estate Investment TrustsFinance Operates real estate investment trusts | Fondateur | - |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Corporate Officer/Principal | - |
Formation de Alan Herman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Merck & Co., Inc.
Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Windrose Medical Properties Trust
Windrose Medical Properties Trust Real Estate Investment TrustsFinance Operates real estate investment trusts | Finance |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indiana University of Pennsylvania
Indiana University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ajinomoto Althea, Inc.
Ajinomoto Althea, Inc. Medical SpecialtiesHealth Technology Provides products and services to support pharmaceutical companies | Health Technology |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
Windrose Analytica, Inc. |
















